help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noy, A.
Right arrow Articles by Bilezikian, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noy, A.
Right arrow Articles by Bilezikian, J. P.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 1223-1231, Copyright © 1994 by Endocrine Society

ARTICLES

Clinical review 63: Diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy

A Noy and JP Bilezikian
Department of Medicine, Columbia-Presbyterian Medical Center, New York, New York 10032.

PURPOSE: To review the relationship between pancreatic cancer and diabetes, particularly as this pertains to the early detection of pancreatic cancer. Data sources: Studies published from 1985 to 1992 identified by computerized literature searches of Index Medicus and Medline and hand searches of referenced articles. Study selection: Selected epidemiology studies were those exploring the relationship between diabetes and pancreatic cancer. Data extraction: Data concerning the risk of developing pancreatic cancer given a history of diabetes was evaluated with particular attention given to the duration of diabetes before a diagnosis of pancreatic cancer. The characteristics of diabetes presenting within the 2 yr before the diagnosis of pancreatic cancer were also investigated. Results of data synthesis: Whereas diabetes is a risk factor for the development of pancreatic cancer, the diagnosis of a pancreatic tumor in some cases is preceded by a brief history of diabetes, which appears to be caused by the malignancy itself. This diabetes may be atypical with regard to a lack of family history of diabetes, absence of obesity, and a rapid progression to insulin dependence. Conclusions: Recognition of atypical diabetes as an early manifestation of pancreatic cancer could lead to earlier diagnosis of tumors at a stage when they are still amenable to resection and cure.


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. Wang, S. Gupta, and E. A. Holly
Diabetes mellitus and pancreatic cancer in a population-based case-control study in the san francisco bay area, california.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1458 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
H. A. Risch
Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity
J Natl Cancer Inst, July 2, 2003; 95(13): 948 - 960.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. M. Gapstur and P. Gann
Is Pancreatic Cancer a Preventable Disease?
JAMA, August 22, 2001; 286(8): 967 - 968.
[Full Text] [PDF]

Home page
 JAMAHome page
S. M. Gapstur, P. H. Gann, W. Lowe, K. Liu, L. Colangelo, and A. Dyer
Abnormal Glucose Metabolism and Pancreatic Cancer Mortality
JAMA, May 17, 2000; 283(19): 2552 - 2558.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society